Filing Details
- Accession Number:
- 0000899243-18-004482
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-20 06:09:57
- Reporting Period:
- 2018-02-15
- Accepted Time:
- 2018-02-20 06:09:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1160308 | Savara Inc | SVRA | Pharmaceutical Preparations (2834) | 841318182 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1703487 | N Robert Neville | 900 S. Capital Of Texas Highway Suite 150 Austin TX 78746 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-02-15 | 15,524 | $12.84 | 414,861 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-02-15 | 9,476 | $13.08 | 405,385 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2017.
- The price reported is a weighted average sale price. The sale prices ranged from $12.21 to $12.99 per share.
- The price reported is a weighted average sale price. The sale prices ranged from $13.00 to $13.71 per share.